News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
294 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39672)
2015 (44432)
2016 (38329)
2017 (37188)
2018 (39119)
2019 (51334)
2020 (57663)
2021 (58720)
2022 (53928)
2023 (42564)
2024 (37441)
2025 (33090)
2026 (19393)
Month
January (3339)
February (3294)
March (4068)
April (3456)
May (4782)
June (3455)
July (2689)
August (3589)
September (3334)
October (3976)
November (4082)
December (2500)
Day
1 (294)
2 (128)
3 (30)
4 (20)
5 (264)
6 (194)
7 (150)
8 (159)
9 (95)
10 (10)
11 (8)
12 (137)
13 (166)
14 (123)
15 (170)
16 (72)
17 (10)
18 (2)
19 (50)
20 (198)
21 (150)
22 (154)
23 (90)
24 (16)
25 (13)
26 (171)
27 (177)
28 (163)
29 (150)
30 (91)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
Can-Fite Reports First Quarter 2023 Financial Results & Provides Clinical Update
Can-Fite BioPharma Ltd today announced financial results for the three months ended March 31, 2023.
June 1, 2023
·
13 min read
Pharm Country
Bristol Myers Squibb to Participate in Upcoming Investor Conferences
Bristol Myers Squibb (NYSE: BMY) today announced that the company will participate in the following investor conferences in June 2023.
June 1, 2023
·
1 min read
Biotech Bay
Adicet Bio to Participate in a Fireside Chat at the 2023 Jefferies Healthcare Conference
Adicet Bio, Inc. today announced that Chen Schor, President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Healthcare Conference being held from June 7-9, 2023 in New York.
June 1, 2023
·
1 min read
Pharm Country
MindMed to Participate at Upcoming Investor Conferences
Mind Medicine announced today that members of the Company’s management team will participate in the following investor conferences.
June 1, 2023
·
1 min read
Business
Switch Therapeutics Announces Formation of Scientific Advisory Board
Switch Therapeutics today announced the formation of its Scientific Advisory Board.
June 1, 2023
·
4 min read
BioMidwest
Xeris Biopharma to Participate at the Jefferies Healthcare Conference
Xeris Biopharma Holdings, Inc. today announced that members of its senior management will participate in a fireside chat at the Jefferies Healthcare Conference on Thursday, June 8 at 10:30am Eastern Time.
June 1, 2023
·
1 min read
Lone Star Bio
Orthofix Announces First Presentation of Seven-Year Outcome Data for the M6-C Artificial Cervical Disc With Other Clinical and Scientific Abstracts at the ISASS Annual Meeting
Orthofix Medical Inc today announced the presentation of multiple clinical and scientific abstracts during the International Society for the Advancement of Spine Surgery (ISASS) annual meeting in San Francisco June 1-3, 2023.
June 1, 2023
·
7 min read
Business
Bausch + Lomb Announces Key Leadership Changes
Bausch + Lomb Corporation announced a reshaping of its executive leadership team, including the elevation of all business unit heads.
June 1, 2023
·
3 min read
Business
LYNPARZA® (olaparib) plus abiraterone approved in the US for the treatment of BRCA-mutated metastatic castration-resistant prostate cancer
LYNPARZA ® (olaparib) plus abiraterone approved in the US for the treatment of BRCA -mutated metastatic castration-resistant prostate cancer.
June 1, 2023
·
25 min read
NeoGenomics to Participate at the Goldman Sachs 44th Annual Global Healthcare Conference
NeoGenomics, Inc. today announced the company will be participating in the upcoming Goldman Sachs 44th Annual Global Healthcare Conference in Dana Point, California.
June 1, 2023
·
1 min read
Previous
7 of 30
Next